Literature DB >> 28162965

Socioeconomic indicators are strong predictors of hepatitis A seroprevalence rates in the Middle East and North Africa.

Mehmet Koroglu1, Kathryn H Jacobsen2, Tayfur Demiray3, Ahmet Ozbek4, Unal Erkorkmaz5, Mustafa Altindis4.   

Abstract

The goal of this analysis was to examine the association between age-specific hepatitis A virus (HAV) seroprevalence rates and various socioeconomic indicators within the Middle East and North Africa (MENA) region. We conducted a systematic review of all recently published studies on HAV conducted in the MENA region and identified the highest quality studies for inclusion in our analysis. We calculated the age at midpoint of population immunity (AMPI) for each study and estimated seroprevalence rates at the ages of 5, 10, and 15 years. Next, we identified the correlations between these metrics and several socioeconomic variables. HAV data collected in or after 2000 were available for 14 of the 19 countries in the MENA region. Four of the 14 included countries had intermediate HAV endemicity (Algeria, Saudi Arabia, Turkey, and UAE), five had high endemicity (Iran, Jordan, Lebanon, Morocco, and Tunisia), and five had very high endemicity (Egypt, Iraq, Palestine, Syria, and Yemen). Water and sanitation were not significant predictors of AMPI or seroprevalence, most likely because most countries in this region have high rates of access to these utilities. However, gross domestic product (GDP), gross national income (GNI), and the human development index (HDI) were all highly associated with AMPI and prevalence. The observed correlations suggest that of the MENA countries without recent HAV data, Bahrain, Kuwait, and Qatar most likely have low endemicity, Oman likely has intermediate endemicity, and Libya likely has high endemicity. While it is unlikely that a single correlation model would be suitable for use in all world regions, the approach utilized in this analysis might provide a simple but accurate method for using economic data to impute the endemicity profiles of countries without recent data in regions where at least several neighboring countries have conducted recent serostudies.
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Drinking water; Hepatitis A; Middle East and North Africa; Seroprevalence; Socioeconomic status

Mesh:

Year:  2017        PMID: 28162965     DOI: 10.1016/j.jiph.2016.09.020

Source DB:  PubMed          Journal:  J Infect Public Health        ISSN: 1876-0341            Impact factor:   3.718


  9 in total

1.  Rapid Salivary IgG Antibody Screening for Hepatitis A.

Authors:  Swinburne A J Augustine; Tarsha N Eason; Kaneatra J Simmons; Shannon M Griffin; Clarissa L Curioso; Malini K D Ramudit; Elizabeth A Sams; Kevin H Oshima; Alfred Dufour; Timothy J Wade
Journal:  J Clin Microbiol       Date:  2020-09-22       Impact factor: 5.948

2.  Declining seroprevalence of hepatitis A in Vojvodina, Serbia.

Authors:  Snežana Medić; Cleo Anastassopoulou; Vesna Milošević; Nataša Dragnić; Smiljana Rajčević; Mioljub Ristić; Vladimir Petrović
Journal:  PLoS One       Date:  2019-06-04       Impact factor: 3.240

3.  Individual and neighborhood socioeconomic status in the prediction of liver transplantation among patients with liver disease: A population-based cohort study in Taiwan.

Authors:  Chi-Chu Liu; Chin-Li Lu; Hari Basuki Notobroto; Chiang-Chin Tsai; Pei-Hung Wen; Chung-Yi Li
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

4.  BCG scar, socioeconomic and nutritional status: a study of newborns in urban area of Makassar, Indonesia.

Authors:  Aldian Irma Amaruddin; Sitti Wahyuni; Firdaus Hamid; Maisuri T Chalid; Maria Yazdanbakhsh; Erliyani Sartono
Journal:  Trop Med Int Health       Date:  2019-04-05       Impact factor: 2.622

Review 5.  Hepatitis A vaccination and its immunological and epidemiological long-term effects - a review of the evidence.

Authors:  Christian Herzog; Koen Van Herck; Pierre Van Damme
Journal:  Hum Vaccin Immunother       Date:  2020-12-16       Impact factor: 3.452

6.  Hepatitis A virus outbreak in Lebanon: Is it a matter of concern?

Authors:  Olivier Uwishema; Mortada Abbass; Anushree Rai; Sara Arab; Rayyan El Saleh; Lama Uweis; Jack Wellington; Felix Musabirema; Irem Adanur; Helen Onyeaka
Journal:  Ann Med Surg (Lond)       Date:  2022-09-13

Review 7.  A review of the experience of childhood hepatitis A vaccination in Saudi Arabia and Turkey: implications for hepatitis A control and prevention in the Middle East and North African region.

Authors:  Selim Badur; Serdar Öztürk; Alev Ozakay; Mansour Khalaf; Debasish Saha; Pierre Van Damme
Journal:  Hum Vaccin Immunother       Date:  2021-07-02       Impact factor: 4.526

8.  Two concurrent outbreaks of hepatitis A highlight the risk of infection for non-immune travellers to Morocco, January to June 2018.

Authors:  Martyna Gassowski; Kai Michaelis; Jürgen J Wenzel; Mirko Faber; Julie Figoni; Lina Mouna; Ingrid Hm Friesema; Harry Vennema; Ana Avellon; Carmen Varela; Lena Sundqvist; Josefine Lundberg Ederth; James Plunkett; Koye Balogun; Siew Lin Ngui; Sofie Elisabeth Midgley; Sofie Gillesberg Lassen; Luise Müller
Journal:  Euro Surveill       Date:  2018-07

9.  Characteristics and potential quality indicators for evaluating pre-travel consultations in Japan hospitals: the Japan Pretravel consultation registry (J-PRECOR).

Authors:  Kei Yamamoto; Yusuke Asai; Issaku Nakatani; Kenichi Hayashi; Hidenori Nakagawa; Koh Shinohara; Shinichiro Kanai; Michitsugu Shimatani; Masaya Yamato; Nobuyuki Shimono; Tsuyoshi Kitaura; Nobuhiro Komiya; Atsushi Nagasaka; Takahiro Mikawa; Akihiro Manabe; Takashi Matono; Yoshihiro Yamamoto; Taku Ogawa; Satoshi Kutsuna; Norio Ohmagari
Journal:  Trop Dis Travel Med Vaccines       Date:  2022-02-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.